精子DNA碎片化与胚胎非整倍体:系统综述与荟萃分析
该PROSPERO注册的系统综述与荟萃分析检索多个数据库至2025年7月10日,纳入报告精子DFI检测与胚胎植入前遗传学检测的观察性研究。7项研究(3563枚胚胎)的荟萃分析显示,高DFI与胚胎非整倍体风险呈显著但 modest 的正相关(合并RR=1.16,95%CI 1.03-1.31),异质性较大(I²=55%)。结论认为现有证据仅来自回顾性研究,尚不足以推荐精子DFI检测作为临床决策的独立指导。
要点
- 高精子DFI与胚胎非整倍体风险呈弱正相关(合并RR=1.16)。
- 该关联在不同亚组中显著性不一致,异质性较大(I²=55%)。
- 证据仅来自回顾性研究,尚不足以推荐DFI作为独立临床决策工具。
核心结论
- 现有证据仅来自回顾性研究,确立高精子DFI与胚胎非整倍体之间的弱关联,但不足以推荐精子DFI检测作为临床决策的独立指导,需前瞻性验证。
研究设计与样本
- PROSPERO注册的系统综述与荟萃分析(CRD420251067930),检索PubMed、Embase、Cochrane Library和Web of Science从建库至2025年7月10日的观察性研究。
- 纳入报告接受ART治疗且进行精子DFI检测和胚胎植入前遗传学检测的夫妇的研究。
- 从601条记录中系统综述11项研究,其中7项研究(3563枚胚胎)纳入荟萃分析。
主要发现
- 7项研究(3563枚胚胎)的荟萃分析显示高精子DFI与胚胎非整倍体风险呈显著但 modest 的正相关(合并RR=1.16,95%CI 1.03-1.31)。
- 异质性较大(I²=55%),该关联的显著性在不同亚组间存在差异。
- 未检测到显著发表偏倚,留一法敏感性分析证实主要发现的稳健性。
关键数值与推荐
- 合并RR=1.16(95%CI 1.03-1.31),对应7项研究、3563枚胚胎,比较高DFI与胚胎非整倍体风险。
- 异质性I²=55%。
临床怎么用
- 目前不推荐将精子DFI检测作为ART夫妇临床决策的独立指导工具。
- DFI与胚胎非整倍体的关联较弱且异质性大,临床解读需谨慎并结合其他因素。
局限性
- 证据仅来自回顾性研究,缺乏前瞻性验证。
- 纳入研究间异质性较大(I²=55%),关联显著性在不同亚组间不一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: What is the association between an elevated sperm DNA fragmentation index (DFI) and the risk of embryonic aneuploidy in couples undergoing assisted reproductive technology (ART) treatment? DESIGN: This PROSPERO-registered systematic review and meta-analysis (CRD420251067930) searched PubMed, Embase, Cochrane Library and Web of Science from inception to 10 July 2025 for observational studies. Studies were included if they reported on couples undergoing ART treatment with sperm DFI testing and preimplantation genetic testing. Heterogeneity was explored via pre-specified subgroup analyses. Robustness was evaluated through sensitivity analyses (leave-one-out method) and assessment of publication bias using funnel plots and Egger's test. RESULTS: From 601 records, 11 studies were systematically reviewed. Meta-analysis of seven studies (3563 embryos) revealed a significant, albeit modest, positive association (pooled RR = 1.16, 95% CI 1.03 to 1.31), with considerable heterogeneity (I² = 55%). The significance of this association varied across subgroups. No significant publication bias was detected, and sensitivity analyses confirmed the robustness of the primary finding. CONCLUSIONS: Current evidence, derived solely from retrospective studies, establishes a modest link but is insufficient to recommend sperm DFI testing as an independent guide for clinical decisions, highlighting the need for prospective validation.
引用
- Zou M, Raffi NA, Noor MM, et al. Sperm DNA fragmentation and embryo aneuploidy: a comprehensive systematic review and meta-analysis. Reprod Biomed Online. 2026. PMID: 42070496. doi:10.1016/j.rbmo.2026.105639
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。